RECRUITING

A Study of Paramedic HF Management

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research is to see if having community paramedic (CP) visit patients at home to manage their heart failure help them stay out of the hospital and improve their overall health compared to standard care. The investigators want to find out if their approach is better for patients in terms of their quality of life, hospital stays, emergency visits, and cost. The investigators are also looking to see how happy patients and doctors are with this method and if it's a practical and sustainable option for the future.

Official Title

Community Paramedic Heart Failure Management (CP-HF) Program

Quick Facts

Study Start:2025-06-24
Study Completion:2026-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06874556

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Adults admitted to the hospital with decompensated HF eligible for early discharge with CP support and monitoring.
  2. 2. Acutely decompensated HF patients at home or being evaluated in the ambulatory clinic who require large volume diuresis but do not require hospital-level monitoring.
  3. 3. Stage D advanced HF patients who require frequent (\>weekly) diuretic adjustments (either inpatient or outpatients).
  1. 1. Hospital-level monitoring or care is clinically indicated.
  2. 2. Failed safety assessment, active substance abuse, or behavioral health diagnosis which could impact participation.
  3. 3. Enrolled in hospice.
  4. 4. Patient is a resident in a skilled nursing facility.
  5. 5. Patient does not have a primary care physician or cardiologist at Mayo Clinic.
  6. 6. Patient participants with communication barriers due to medical illness or cognitive impairment.
  7. 7. Pregnant

Contacts and Locations

Study Contact

Sara Biorn
CONTACT
507-266-2328
Biorn.Sara@mayo.edu

Principal Investigator

Sara Severson, APRN, C.N.P.
PRINCIPAL_INVESTIGATOR
Mayo Clinic

Study Locations (Sites)

Mayo Clinic
Rochester, Minnesota, 55905
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Sara Severson, APRN, C.N.P., PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-06-24
Study Completion Date2026-03

Study Record Updates

Study Start Date2025-06-24
Study Completion Date2026-03

Terms related to this study

Additional Relevant MeSH Terms

  • Heart Failure